163 related articles for article (PubMed ID: 24523874)
1. TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis.
Lu M; Tian H; Yue W; Li L; Li S; Qi L; Hu W; Gao C; Si L
PLoS One; 2014; 9(2):e88032. PubMed ID: 24523874
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TFIIB-related factor 2 is significantly correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer.
Lu M; Tian H; Yue W; Li L; Li S; Qi L; Hu W; Gao C; Si L
Med Oncol; 2013 Jun; 30(2):553. PubMed ID: 23550276
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis.
Wang XW; Cai CL; Xu JM; Jin H; Xu ZY
Tumour Biol; 2015 Feb; 36(2):901-7. PubMed ID: 25304157
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Li SH; Tian H; Yue WM; Li L; Li WJ; Chen ZT; Hu WS; Zhu YC; Qi L
Ann Surg Oncol; 2011 Jul; 18(7):2048-56. PubMed ID: 21290196
[TBL] [Abstract][Full Text] [Related]
5. GOLPH3, a good prognostic indicator in early-stage NSCLC related to tumor angiogenesis.
Lu M; Tian Y; Yue WM; Li L; Li SH; Qi L; Hu WS; Gao C; Si LB; Tian H
Asian Pac J Cancer Prev; 2014; 15(14):5793-8. PubMed ID: 25081702
[TBL] [Abstract][Full Text] [Related]
6. TFIIB-related factor 2 is associated with poor prognosis of nonsmall cell lung cancer patients through promoting tumor epithelial-mesenchymal transition.
Tian Y; Lu M; Yue W; Li L; Li S; Gao C; Si L; Qi L; Hu W; Tian H
Biomed Res Int; 2014; 2014():530786. PubMed ID: 24738062
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer.
Cui J; Tian H; Chen G
Ann Thorac Surg; 2015 Aug; 100(2):465-72. PubMed ID: 26095102
[TBL] [Abstract][Full Text] [Related]
9. Silencing of BRF2 inhibits the growth and metastasis of lung cancer cells.
Bian Y; Li Q; Li Q; Pan R
Mol Med Rep; 2020 Sep; 22(3):1767-1774. PubMed ID: 32705258
[TBL] [Abstract][Full Text] [Related]
10. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.
Lockwood WW; Chari R; Coe BP; Thu KL; Garnis C; Malloff CA; Campbell J; Williams AC; Hwang D; Zhu CQ; Buys TP; Yee J; English JC; Macaulay C; Tsao MS; Gazdar AF; Minna JD; Lam S; Lam WL
PLoS Med; 2010 Jul; 7(7):e1000315. PubMed ID: 20668658
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
Mineo TC; Ambrogi V; Baldi A; Rabitti C; Bollero P; Vincenzi B; Tonini G
J Clin Pathol; 2004 Jun; 57(6):591-7. PubMed ID: 15166262
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 8 overexpression is correlated with angiogenesis and poor prognosis in gastric cancer.
Wang WF; Li J; Du LT; Wang LL; Yang YM; Liu YM; Liu H; Zhang X; Dong ZG; Zheng GX; Wang CX
World J Gastroenterol; 2013 Jul; 19(27):4309-15. PubMed ID: 23885141
[TBL] [Abstract][Full Text] [Related]
13. BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.
Tian Y; Wang C; Lu M
Surg Today; 2019 Feb; 49(2):158-169. PubMed ID: 30182305
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer.
Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M
Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of platelet endothelial cell adhesion molecule-1 in non-small-cell lung cancer patients.
Kuang BH; Wen XZ; Ding Y; Peng RQ; Cai PQ; Zhang MQ; Jiang F; Zhang XS; Zhang X
Med Oncol; 2013 Jun; 30(2):536. PubMed ID: 23494670
[TBL] [Abstract][Full Text] [Related]
16. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
[TBL] [Abstract][Full Text] [Related]
17. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
18. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H
Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817
[TBL] [Abstract][Full Text] [Related]
19. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W
IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
